The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels

Roberto Fogari, Annalisa Zoppi, Franco Tettamanti, Giandomenico Malamani, Carlo Pasotti

Research output: Contribution to journalArticle

Abstract

The aim of this study was to compare the effects of chronic antihypertensive therapy with either celiprolol or atenolol on plasma lipids in patients with hypercholesterolemia. Forty-six patients with essential hypertension and a total cholesterol (TC) concentration > 220 mg/dl were studied. After 1 month on placebo, patients were stratified into five classes on the basis of their plasma TC levels and then randomized to receive atenolol 100 mg/day or celiprolol 400 mg/day for 1 year. Blood pressure (BP), heart rate (HR), and blood samples for evaluation of TC, HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), and triglycerides (TG) were taken before and after the placebo period, and every 6 months from the beginning of the active treatment. Celiprolol and atenolol caused similar reduction in BP. Both atenolol and celiprolol decreased TC. Atenolol significantly reduced HDL-C, while celiprolol increased it (p

Original languageEnglish
Pages (from-to)1287-1290
Number of pages4
JournalCardiovascular Drugs and Therapy
Volume4
Issue number6 Supplement
DOIs
Publication statusPublished - Jan 1991

Fingerprint

Celiprolol
Atenolol
Hypercholesterolemia
Lipids
Cholesterol
HDL Cholesterol
Placebos
Blood Pressure
LDL Cholesterol
Antihypertensive Agents
Heart Rate
Therapeutics

Keywords

  • beta blockers
  • celiprolol
  • hypercholesterolemia
  • hypertension
  • lipids

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels. / Fogari, Roberto; Zoppi, Annalisa; Tettamanti, Franco; Malamani, Giandomenico; Pasotti, Carlo.

In: Cardiovascular Drugs and Therapy, Vol. 4, No. 6 Supplement, 01.1991, p. 1287-1290.

Research output: Contribution to journalArticle

Fogari, R, Zoppi, A, Tettamanti, F, Malamani, G & Pasotti, C 1991, 'The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels', Cardiovascular Drugs and Therapy, vol. 4, no. 6 Supplement, pp. 1287-1290. https://doi.org/10.1007/BF00114235
Fogari, Roberto ; Zoppi, Annalisa ; Tettamanti, Franco ; Malamani, Giandomenico ; Pasotti, Carlo. / The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels. In: Cardiovascular Drugs and Therapy. 1991 ; Vol. 4, No. 6 Supplement. pp. 1287-1290.
@article{2510358a1c0e459a9219e1f1dbf9a681,
title = "The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels",
abstract = "The aim of this study was to compare the effects of chronic antihypertensive therapy with either celiprolol or atenolol on plasma lipids in patients with hypercholesterolemia. Forty-six patients with essential hypertension and a total cholesterol (TC) concentration > 220 mg/dl were studied. After 1 month on placebo, patients were stratified into five classes on the basis of their plasma TC levels and then randomized to receive atenolol 100 mg/day or celiprolol 400 mg/day for 1 year. Blood pressure (BP), heart rate (HR), and blood samples for evaluation of TC, HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), and triglycerides (TG) were taken before and after the placebo period, and every 6 months from the beginning of the active treatment. Celiprolol and atenolol caused similar reduction in BP. Both atenolol and celiprolol decreased TC. Atenolol significantly reduced HDL-C, while celiprolol increased it (p",
keywords = "beta blockers, celiprolol, hypercholesterolemia, hypertension, lipids",
author = "Roberto Fogari and Annalisa Zoppi and Franco Tettamanti and Giandomenico Malamani and Carlo Pasotti",
year = "1991",
month = "1",
doi = "10.1007/BF00114235",
language = "English",
volume = "4",
pages = "1287--1290",
journal = "Cardiovascular Drugs and Therapy",
issn = "0920-3206",
publisher = "Kluwer Academic Publishers",
number = "6 Supplement",

}

TY - JOUR

T1 - The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels

AU - Fogari, Roberto

AU - Zoppi, Annalisa

AU - Tettamanti, Franco

AU - Malamani, Giandomenico

AU - Pasotti, Carlo

PY - 1991/1

Y1 - 1991/1

N2 - The aim of this study was to compare the effects of chronic antihypertensive therapy with either celiprolol or atenolol on plasma lipids in patients with hypercholesterolemia. Forty-six patients with essential hypertension and a total cholesterol (TC) concentration > 220 mg/dl were studied. After 1 month on placebo, patients were stratified into five classes on the basis of their plasma TC levels and then randomized to receive atenolol 100 mg/day or celiprolol 400 mg/day for 1 year. Blood pressure (BP), heart rate (HR), and blood samples for evaluation of TC, HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), and triglycerides (TG) were taken before and after the placebo period, and every 6 months from the beginning of the active treatment. Celiprolol and atenolol caused similar reduction in BP. Both atenolol and celiprolol decreased TC. Atenolol significantly reduced HDL-C, while celiprolol increased it (p

AB - The aim of this study was to compare the effects of chronic antihypertensive therapy with either celiprolol or atenolol on plasma lipids in patients with hypercholesterolemia. Forty-six patients with essential hypertension and a total cholesterol (TC) concentration > 220 mg/dl were studied. After 1 month on placebo, patients were stratified into five classes on the basis of their plasma TC levels and then randomized to receive atenolol 100 mg/day or celiprolol 400 mg/day for 1 year. Blood pressure (BP), heart rate (HR), and blood samples for evaluation of TC, HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), and triglycerides (TG) were taken before and after the placebo period, and every 6 months from the beginning of the active treatment. Celiprolol and atenolol caused similar reduction in BP. Both atenolol and celiprolol decreased TC. Atenolol significantly reduced HDL-C, while celiprolol increased it (p

KW - beta blockers

KW - celiprolol

KW - hypercholesterolemia

KW - hypertension

KW - lipids

UR - http://www.scopus.com/inward/record.url?scp=0025691398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025691398&partnerID=8YFLogxK

U2 - 10.1007/BF00114235

DO - 10.1007/BF00114235

M3 - Article

C2 - 1826213

AN - SCOPUS:0025691398

VL - 4

SP - 1287

EP - 1290

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

SN - 0920-3206

IS - 6 Supplement

ER -